The conclusion of the study was that grape powder containing low doses of resveratrol in combination with other bioactive components suppressed the expression of Wnt target genes, cyclin D1 and axin in normal colonic mucosa, suggesting that Wnt pathway inhibition might contribute to resveratrol-mediated colon cancer prevention. The gene discussed is CCND1; the disease is malignant colon neoplasm.